H. Kerr Graham, MD, FRCS (Ed), FRACS
Professor of Orthopaedic Surgery
Director of the Hugh Williamson Gait Laboratory
The Royal Children's Hospital
H. Kerr Graham is The University of Melbourne Professor of Orthopaedic Surgery, Director of the Hugh Williamson Gait Laboratory, and a Consultant Orthopaedic Surgeon at The Royal Children's Hospital in Melbourne. Professor Graham's clinical and research interests are principally in the area of cerebral palsy, clinical gait analysis, clinical trials of spasticity management, and gait improvement surgery for children with cerebral palsy.
In 1993 and 1995 his research team was awarded the Richmond prize from the American Academy of Cerebral Palsy and Developmental Medicine in recognition of pioneering work in the use of Botulinum toxin A for the management of spasticity in children with cerebral palsy. Since then, several commercial preparations of Botulinum toxin A have been licensed and approved for use in children with cerebral palsy in many countries around the world. In 2001 he was awarded the John Mitchell Crouch Fellowship, the highest research award from the Royal Australasian College of Surgeons. In 2002 he received the prize for the Best Basic Science paper at the Annual Meeting of the Pediatric Orthopaedic Society of North America (POSNA).
Professor Graham runs an active clinical and research program through the Hugh Williamson Gait Laboratory at The Royal Children's Hospital, Melbourne. He has supervised 6 MDs and 7 PhDs to completion leading to an extensive publication of original papers, review articles, and book chapters. Between 2005 and 2009, Professor Graham was the Chief Investigator of the National Health and Medical Research Council of Australia Clinical Centre of Research Excellence in Gait Rehabilitation (NH&MRC CCRE), which led to the publication of 11 book chapters and 160 papers.
Professor Graham has developed a number of patents including enhancement of longitudinal muscle growth in the hereditary spastic mouse and in the development of novel software in clinical gait analysis, the Movement Analysis Profile (MAP) and Gait Profile Score (GPS). He has served as Visiting Professor in the United States, Canada, South America, Southeast Asia, Europe, and the United Kingdom. He is currently a board member of the Neurotoxin Institute and was recently appointed to the Board of Directors of the American Academy of Cerebral Palsy and Developmental Medicine. He serves as Associate Editor for Developmental Medicine and Child Neurology (DMCN) and is an editorial board member for several journals including DMCN and the Journal of Pediatric Orthopaedics.